Merlin Protein

Merlin Protein — Neurofibromin 2

Introduction

Merlin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Merlin Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Merlin (moesin-ezrin-radixin-like protein)</td></tr>
<tr><td><strong>Gene</strong></td><td>[NF2](/genes/nf2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P35240](https://www.uniprot.org/uniprot/P35240)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1H4R, 4X3V</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>70 kDa (595 aa)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Membrane, Cytoskeleton, Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>FERM domain protein family (ERM)</td></tr>
</table>
</div>

Overview

MERLIN (Merlin (NF2 Tumor Suppressor)) is a protein encoded by a gene located on chromosome 22q12.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. MERLIN plays important roles in neuronal function and is implicated in neurodegenerative diseases.

Structure

Merlin (also called schwannomin) is a member of the ERM (ezrin-radixin-moesin) protein family:

...

Merlin Protein — Neurofibromin 2

Introduction

Merlin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Merlin Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Merlin (moesin-ezrin-radixin-like protein)</td></tr>
<tr><td><strong>Gene</strong></td><td>[NF2](/genes/nf2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P35240](https://www.uniprot.org/uniprot/P35240)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1H4R, 4X3V</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>70 kDa (595 aa)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Membrane, Cytoskeleton, Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>FERM domain protein family (ERM)</td></tr>
</table>
</div>

Overview

MERLIN (Merlin (NF2 Tumor Suppressor)) is a protein encoded by a gene located on chromosome 22q12.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. MERLIN plays important roles in neuronal function and is implicated in neurodegenerative diseases.

Structure

Merlin (also called schwannomin) is a member of the ERM (ezrin-radixin-moesin) protein family:

• FERM domain (N-terminal): Protein and membrane binding
• Alpha-helical domain: Dimerization
• C-terminal domain: Actin binding
• Phosphorylation sites: Regulatory control

Unique features compared to other ERM proteins:

• C-terminal actin-binding site is masked
• Functions as a tumor suppressor
• Localization is tightly regulated

Normal Function

Merlin functions as a scaffold protein regulating multiple signaling pathways:

• Hippo pathway: Activates YAP/TAZ inhibition
• [mTOR](/entities/mtor) signaling: Inhibits mTORC1
• Ras-MAPK: Negatively regulates Ras signaling
• Rac signaling: Controls cytoskeletal dynamics
• Notch signaling: Regulates cell fate decisions
• Contact inhibition: Mediates cell density sensing

In the nervous system:

• Controls Schwann cell proliferation
• Regulates meningeal cell growth
• Maintains neuronal polarity
• Essential for proper myelination

Role in Disease

Neurofibromatosis Type 2

• Bilateral vestibular schwannomas (acoustic neuromas)
• Meningiomas (multiple)
• Ependymomas
• NF2 is the second most common inherited tumor syndrome

Schwannomatosis

• Multiple schwannomas without vestibular involvement
• Can be NF2-related or sporadic

Meningiomas

• Most common primary brain tumor
• NF2 mutations in ~60% of sporadic meningiomas

Therapeutic Targeting

| Approach | Drug/Agent | Status | Mechanism |
|----------|------------|--------|-----------|
| [mTOR](/mechanisms/mtor-signaling-pathway) inhibitors | Everolimus, Temsirolimus | Clinical | Suppress tumor growth |
| VEGF inhibitors | Bevacizumab | Clinical | Anti-angiogenic |
| FAK inhibitors | Defactinib | Clinical | Block survival signaling |
| MEK inhibitors | Selumetinib | Preclinical | Block proliferation |
| Radiotherapy | Gamma Knife | Standard care | Tumor control |

Key Publications

[8348146](https://pubmed.ncbi.nlm.nih.gov/8348146/): NF2 gene identified. Cell, 1993.

[12799620](https://pubmed.ncbi.nlm.nih.gov/12799620/): Merlin tumor suppressor. Nat. Rev. Cancer, 2003.

[23972009](https://pubmed.ncbi.nlm.nih.gov/23972009/): Merlin in CNS. Nat. Rev. Neurosci, 2013.

[26497676](https://pubmed.ncbi.nlm.nih.gov/26497676/): NF2 therapeutics. Nat. Rev. Neurol, 2015.

See Also

• [NF2 Gene](/genes/nf2)
• [Neurofibromatosis Type 2](/diseases/neurofibromatosis-type-2)
• [Schwannomatosis](/diseases/schwannomatosis)
• [Meningiomas](/diseases/meningiomas)
• [Hippo Signaling](/mechanisms/hippo-signaling)

Background

The study of Merlin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

<references>

• Rouleau GA, et al. (1993). NF2 gene. Cell 72: 971-983.
• McClatchey AI, et al. (2003). Merlin tumor suppressor. Nat Rev Cancer 3: 294-303.
• Li W, et al. (2013). Merlin in CNS. Nat Rev Neurosci 14: 416-424.
• Agnihotri S, et al. (2015). NF2 therapeutics. Nat Rev Neurol 11: 617-628.

</references>